Fidelity Select Portfolios - Medical Technology and Devices Portfolio Net Tangible Assets

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) currently reports a net tangible assets of $180M as of September 2023. That compares with $180M in the prior-year period — up 0.1% year over year. Use the charts on this page to explore Fidelity Select Portfolios - Medical Technology and Devices Portfolio's net tangible assets history and peer comparisons.

Fidelity Select Portfolios - Medical Technology and Devices Portfolio's net tangible assets increased from $180M to $180M — a 0.1% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fidelity Select Portfolios - Medical Technology and Devices Portfolio reported $180M in net tangible assets as of September 2023. That compares with $180M in the prior-year period — up 0.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fidelity Select Portfolios - Medical Technology and Devices Portfolio, and consider following FSMEX for alerts when major investors trade the stock.